脆弱なアテローム性動脈硬化性冠動脈プラークに対する予防的PCIまたは薬物療法のみ

基本情報

NCT ID

NCT02316886

ステータス

完了

試験のフェーズ

第4相

試験タイプ

介入

目標被験者数

1,608

治験依頼者名

Asan Medical Center

概要

The primary aim of the trial is to determine whether preventive PCI with bioabsorbable vascular scaffolds (BVS) (early period) or everolimus-eluting stents (middle and late period) plus optimal medical therapy (OMT) on functionally insignificant (FFR \> 0.80) vulnerable coronary plaque, as determined by intracoronary imaging, would result in a significant reduction of the primary composite outcome of death from cardiac causes, target-vessel myocardial infarction (MI), target-vessel revascularization (TVR), and hospitalization for unstable or progressive angina at 2 years, when compared with OMT alone.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)